Elevance Health, Inc. (ELV)

Elevance Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	5,237	5,661	5,971	5,991	5,888	6,149
Depreciation & Amortization	1,726	1,745	1,546	1,393	1,675	1,302
Stock-Based Compensation	250	276	191	289	264	255
Other Adjustments	-647	84	-28	571	149	-465
Change in Receivables	-526	-2,526	-683	-1,762	-2,510	-2,138
Changes in Accounts Payable	1,214	-720	-272	1,640	824	719
Changes in Income Taxes Payable	-10	-297	404	-103	-338	140
Changes in Unearned Revenue	119	-15	-113	290	-42	-113
Changes in Other Operating Activities	1,199	1,105	-2,554	75	2,489	2,515
Operating Cash Flow	7,605	4,290	5,808	8,061	8,399	8,364
Operating Cash Flow Growth	56.90%	-26.14%	-27.95%	-4.02%	0.42%	-21.74%
Capital Expenditures	-1,155	-1,116	-1,256	-1,296	-1,152	-1,087
Purchases of Investments	-15,797	-15,026	-17,986	-16,236	-24,946	-18,669
Proceeds from Sale of Investments	14,167	15,095	18,572	13,536	22,608	14,613
Payments for Business Acquisitions	89	88	-4,809	-1,552	-649	-3,476
Proceeds from Business Divestments	-	-	363	-	-	-
Other Investing Activities	-517	-509	-29	78	-421	-1,019
Investing Cash Flow	-3,089	-1,344	-5,167	-5,572	-4,560	-9,638
Short-Term Debt Issued	1,239	1,505	275	225	1,365	1,375
Short-Term Debt Repaid	-1,323	-1,720	-135	-265	-1,675	-1,050
Net Short-Term Debt Issued (Repaid)	-83.5	-215	140	-40	-310	325
Long-Term Debt Issued	2,991	2,991	7,710	2,574	3,071	3,462
Long-Term Debt Repaid	-1,647	-2,147	-1,650	-1,909	-1,899	-1,068
Net Long-Term Debt Issued (Repaid)	1,344	844	6,060	665	1,172	2,394
Issuance of Common Stock	93	79	221	152	182	203
Repurchase of Common Stock	-2,849	-2,605	-2,900	-2,676	-2,316	-1,900
Net Common Stock Issued (Repurchased)	-2,756	-2,526	-2,679	-2,524	-2,134	-1,697
Common Dividends Paid	-1,519	-1,529	-1,508	-1,395	-1,229	-1,104
Other Financing Activities	113	1,688	-820	-55	1,183	505
Financing Cash Flow	-2,344	-1,738	1,193	-3,349	-1,318	423
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-15	-5	-6	-1	-14	-10
Net Cash Flow	2,157	1,203	1,828	-861	2,507	-861
Free Cash Flow	6,450	3,174	4,552	6,765	7,247	7,277
Free Cash Flow Growth	103.21%	-30.27%	-32.71%	-6.65%	-0.41%	-24.72%
FCF Margin	3.25%	1.61%	2.60%	3.97%	4.66%	5.31%
Free Cash Flow Per Share	28.93	14.13	19.54	28.50	29.85	29.49
Levered Free Cash Flow	9,597	6,993	9,935	8,611	10,212	12,353
Unlevered Free Cash Flow	7,751	6,246	3,256	7,912	9,279	8,950

Updated Apr 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q